The human factor IX gene as germline mutagen test: Samples from Mainland China have the putatively endogenous pattern of mutation

Human Mutation

Volumn 16, Issue 1, 2000, Pages 31-36

  Liu, Jing Zhong ^a   Li, Xuemin ^b   Drost, Joni ^b   Thorland, Erik C ^c   Liu, Qiang ^b   Lind, Tammy ^c   Roberts, Stacy ^c   Wang, H Y ^a   Sommer, Steve S ^b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^c MAYO CLINIC   (United States)

Author keywords

Caucasian; China; Endogenous mutagens; Exogenous mutagens; F9; Factor IX; Hemophilia B; Pattern of mutation

Indexed keywords

BLOOD CLOTTING FACTOR 9;

AMINO ACID SUBSTITUTION; ARTICLE; CHINA; CONTROLLED STUDY; DISEASE SEVERITY; ETHNIC DIFFERENCE; GENE MUTATION; GENETIC PREDISPOSITION; HEMOPHILIA B; HUMAN; MAJOR CLINICAL STUDY; MUTATION RATE; PRIORITY JOURNAL;

CHINA; EUROPEAN CONTINENTAL ANCESTRY GROUP; FACTOR IX; FEMALE; GERM-LINE MUTATION; HEMOPHILIA B; HUMANS; MALE; MUTAGENESIS, SITE-DIRECTED; PATTERN RECOGNITION, AUTOMATED;

MAMMALIA;

EID: 0033920931     PISSN: 10597794     EISSN: None     Source Type: Journal    
DOI: 10.1002/1098-1004(200007)16:1<31::AID-HUMU6>3.0.CO;2-I     Document Type: Article

References (33)

1. 1 induces the transversion of G→T in codon 249 of the p53 tumor suppressor gene in human hepatocytes. Proc Natl Acad Sci USA 90:8586-8590.
2. Bottema CDK, Ketterling RP, Yoon H-S, Sommer SS. 1990a. The pattern of factor IX germline mutation in Asians is similar to that of Caucasians. Am J Hum Genet 47:835-841.
3. Bottema CDK, Ketterling RP, Koeberl DD, Taylor SA, Sommer SS. 1990b. Mutations at arginine residues in two Asian hemophilia B patients. Nucleic Acids Res 18:1924.
4. Bottema CDK, Ketterling RP, Ii S, Yoon H-S, Phillips JA III, Sommer SS. 1991a. Missense mutations and evolutionary conservation of amino acids: evidence that many of the amino acids in factor IX function as "spacer" elements. Am J Hum Genet 49:820-838.
5. Bottema CDK, Bottema MJ, Ketterling RP, Yoon H-S, Janco RL, Phillips JA, III, Sommer SS. 1991b. Why does the human factor IX gene have a G + C content of 40%? Am J Hum Genet 49:839-850.
6. Bottema CDK, Sarkar G, Cassady JD, Ii S, Dutton CM, Sommer SS. 1993. Polymerase chain reaction amplification of specific alleles: a general method of detection of mutations, polymorphisms, and haplotypes. In: Methods in enzymology. Wu R, ed. San Diego: Academic Press. p 388-402.
7. Brash DE, Rudolph JA, Simon JA, Lin A, McKenna GJ, Baden HP, Halperin AJ, Ponten J. 1991. A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci USA 88:10124-10128.
8. Bressac B, Kew M, Wands J, Ozturk M. 1991. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature 350:429-431.
9. Cavalli-Sforza LL, Menozzi P, Piazza A. 1994. The history and geography of human genes. Princeton: Princeton University Press.
10. Chiba I, Takahashi T, Nau MM, D'Amico D, Curiel DT, Mitsudomi T, Buchhagen DL, Carbone D, Piantadosi S, Koga H. 1990. Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Lung Cancer Study Group. Oncogene 5:1603-1610.
11. Ghanem N, Costes B, Martin J, Vidaud M, Rothschild C, Foyer-Gazengel C, Goossens M. 1993. Twenty-four novel hemophilia B mutations revealed by rapid scanning of the whole factor IX gene in a French population sample. Eur J Hum Genet 1:144-155.
12. Giannelli F, Green PM, Sommer SS, Poon M, Ludwig M, Schwaab R, Reitsma PH, Goossens M, Yoshioka A, Figueiredo MA, Brownlee GG. 1998. Haemophilia B: database of point mutations and short additions and deletions-eighth edition. Nucleic Acids Research 26(1):265-268.
13. Gostout B, Vielhaber E, Ketterling RP, Yoon H-S, Bottema CDK, Kasper CK, Koerper M, Sommer SS. 1993. Germline mutations in the factor IX gene: a comparison of the pattern in Caucasians and non-Caucasians. Hum Molec Genet 2:293-298.
14. Hartmann A, Blaszyk H, Kovach JS, Sommer SS. 1997. The molecular epidemiology of p53 gene mutations in human breast cancer. Trends Genet 13:27-33.
15. Hsu IC, Metcalf RA, Sun T, Welsh JA, Wang NJ, Harris CC. 1991. Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature 350:427-428.
16. Ketterling RP, Vielhaber E, Sommer SS. 1994. The rates of G:C→T:A and G:C→C:G transversions at CpG dinucleotides in the human factor IX gene. Am J Hum Genet 54:831-835.
17. Ketterling RP, Drost JB, Scaringe WA, Liao D, Liu J-Z, Kasper CK, Sommer SS. 1999. Reported in vivo splice-site mutations in the factor IX gene: severity of splicing defects and a hypothesis for predicting deleterious splice donor mutations. Hum Mutat 13:221-231.
18. Knobloch O, Zoll B, Zerres K, Brackmann H-H, Olek K, Ludwig M. 1993. Recurrent mutations in the factor IX gene: founder effect or repeat de novo events. Hum Genet 92:40-48.
19. Koeberl DD, Bottema CDK, Ketterling RP, Bridge PJ, Lillicrap DP, Sommer SS. 1990. Mutations causing hemophilia B: direct estimate of the underlying rates of spontaneous germline transitions, transversions, and deletions in the human gene. Am J Hum Genet 47:202-217.
20. Liu J-Z, Gao QS, Jiang Z, Liang CC, Yang KG, Wu GY, Long GF, Li Q, Zhang J, Deng B. 1989. Studies of beta-thalassemia mutations in familes living in three provinces in southern China. Hemoglobin 13:585-595.
21. Liu Q, Sommer SS. 1995. Restriction endonuclease fingerprinting (REF): a sensitive method for screening mutations in long, contiguous segments of DNA. BioTechniques 18:470-477.
22. Montandon AJ, Green PM, Bentley DR, Ljung R, Kling S, Nilsson IM, Giannelli F. 1992. Direct estimate of the haemophilia B (factor IX deficiency) mutation rate and of the ratio of the sex-specific mutation rates in Sweden. Hum Genet 89:319-322.
23. Nielsen LR, Scheibel E, Ingerslev J, Schwartz M. 1995. Detection of ten new mutations by screening the gene encoding factor IX of Danish hemophilia B patients. Thromb Haemost 73:774-778.
24. Saad S, Rowley G, Tagliavacca L, Green PM, Giannelli F, UK Haemophilia Centers. 1994. First report on UK database of haemophilia B mutations and pedigrees. Thromb Haemost 71:563-570.
25. Sarkar G, Yoon H-S, Sommer SS. 1992. Dideoxy fingerprinting (ddF): a rapid and efficient screen for the presence of mutations. Genomics 13:441-443.
26. Sommer SS. 1990. Mutagen test. Nature 346:22-23.
27. Sommer SS, Sarkar G, Koeberl DD, Bottema CDK, Buerstedde JM, Schowalter DB, Cassady JD. 1990. Direct sequencing with the aid of phage promoters. In: PCR protocols: a guide to methods and applications. Innis MA, Gelfand DH, Sninsky JJ, White TJ, eds. New York: Academic Press. p 197-205.
28. Sommer SS, Bowie EJW, Ketterling RP, Bottema CDK. 1992. Missense mutations and the magnitude of functional deficit: the example of factor IX. Hum Genet 89:295-297.
29. Sommer SS, Ketterling RP. 1996. The factor IX gene as a model for analysis of human germline mutations: an update. Hum Mol Genet 5:1505-1514.
30. Stoflet ES, Koeberl DD, Sarkar G, Sommer SS. 1988. Genomic amplification with transcript sequencing. Science 239:491-494.
31. Suzuki DT, Griffiths AJF, Miller JH, Lewontin RC. 1989. An introduction to genetic analysis, 4th ed. New York: WH Freeman and Company.
32. Thorland EC, Weinshenker BG, Liu J-Z, Ketterling RP, Vielhaber EL, Kasper CK, Ambriz R, Paredes R, Sommer SS. 1995. Molecular epidemiology of factor IX germline mutations in Mexican Hispanics: pattern of mutation and potential founder effects. Thromb Haemost 74:1416-1422.
33. Vielhaber E, Jacobson DP, Ketterling RP, Liu J-Z, Sommer SS. 1993. A mutation in the 3′ untranslated region of the factor IX gene in four families with hemophilia B. Hum Molec Genet 2:1309-1310.